retatrutide triple agonist phase 2 nejm 2023 obesity results The trial that put “24%” on the map Retatrutide: A Triple Agonist Shaping

Suitable for horses, dogs, and cats

Do not administer a dose less than two hours before bedtime due to a risk of suppressing natural growth hormone synthesis

Maximum microdose ceiling: 1.25 mg weekly Tirzepatide brings an interesting additional dimension

After numerous manipulations on candidate molecules, one was arrived at that acted as a non-peptide GLP-1 agonist and was given the name orforglipron. Now came the next challenge

Both GLP-1 and GLP-1/GIP receptor agonists, which include dulaglutide, exenatide, liraglutide, semaglutide, and tirzepatide, have been linked to rare pancreatitis cases

This range extrapolates from effective animal doses using standard interspecies scaling calculations